Search This Blog

Thursday, June 9, 2022

Thermo Fisher tests cleared by FDA

 Thermo Fisher Scientific Inc. said the Food and Drug Administration has cleared its Thermo Scientific EliA RNA Pol III and EliA Rib-P tests for aiding in the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematosus.

With these new tests, the company said, the EliA portfolio provides a more robust clinical offering through a comprehensive menu of automated connective tissue disease tests.

RNA Polymerase III is a criteria marker for SSc with both diagnostic and prognostic value. Also, in patients who are positive for RNA Polymerase III, up to 70% may have no other SSc associated antibodies present. The EliA RNA Pol III test completes a criteria based EliA SSc panel and is the first fully automated RNA Polymerase test available in the U.S.

The EliA Rib-P test is designed with optimal sensitivity and specificity and can be used to support the diagnosis of SLE, particularly in ANA negative patients.

https://www.marketscreener.com/quote/stock/THERMO-FISHER-SCIENTIFIC-14623/news/Thermo-Fisher-Scientific-Tests-Get-FDA-Clearance-40681947/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.